CalciMedica, Inc.
CalciMedica, Inc. (CALC): 6 pipeline candidates · ~5 mo cash runway · 4 clinical trials. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
5.1 months
D/E -8.80 · 4% dilution
Lead: Phase 2
6 candidates
N/A
N/A
A transparent, data-derived signal for CalciMedica, Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$13.7M
Cash
$8.2M
Quarterly Burn
$4.9M
Runway
5.1 mo
Revenue
—
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (6 candidates)
| Drug | Phase |
|---|---|
| Auxora | Phase 2 |
| cm4620 injectable emulsion | Phase 2 |
| cm4620-ie | Phase 2 |
| CM5480 | Preclinical |
| CM6336 | Preclinical |
| zegocractin (oral, preclinical administration) | Preclinical |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
28
Total value held
$618K
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 338,220 | $183K |
| jane street group, llc | 178,515 | $96K |
| renaissance technologies llc | 128,075 | $69K |
| 180 wealth advisors, llc | 126,500 | $68K |
| geode capital management, llc | 123,382 | $67K |
| stonehage fleming financial services holdings ltd | 53,703 | $29K |
| vanguard fiduciary trust co | 45,829 | $25K |
| susquehanna international group, llp | 30,716 | $17K |
| citadel advisors llc | 18,200 | $10K |
| state street corp | 17,073 | $9K |
Showing top 10 of 28 institutional holders of CalciMedica, Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in CalciMedica, Inc.'s pipeline?
CalciMedica, Inc. (CALC) has 6 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is CalciMedica, Inc.'s lead drug candidate?
CalciMedica, Inc.'s most advanced tracked candidate is Auxora (Phase 2) for Pneumonia.
What is CalciMedica, Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, CalciMedica, Inc. has approximately 5.1 months of cash runway.
What is CalciMedica, Inc.'s market capitalization?
CalciMedica, Inc.'s market capitalization is approximately $13.7M.
Who is the CEO of CalciMedica, Inc.?
Dr. A. Rachel Leheny Ph.D. is the chief executive officer of CalciMedica, Inc. (CALC).
Get the full picture on CalciMedica, Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.